Date

Title

  • Feb 23, 2025

    Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting

  • Jan 9, 2025

    2024 Year in Review: Complete Genomics’ Innovations and Impact

  • Dec 17, 2024

    Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

  • Nov 20, 2024

    Complete Genomics announces mpox virus amplicon sequencing panel at AMP

  • Nov 5, 2024

    Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024

  • Nov 4, 2024

    Complete Genomics Highlights Innovation with Expanded Multi-Omics and Spatial Transcriptomics Applications at ASHG 2024

  • Oct 29, 2024

    Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis

  • Oct 8, 2024

    Complete Genomics to Congress: BIOSECURE Act is unconstitutional, violates due process protections

  • Sep 23, 2024

    AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.

  • Sep 11, 2024

    There’s still time for the Senate to Fix the BIOSECURE Act 

  • May 23, 2024

    Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 

  • May 21, 2024

    Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston’s Biotech Hub 

  • May 15, 2024

    An Update to the Genomics Community on the BIOSECURE Act

  • May 13, 2024

    The BIOSECURE Act Is Grounded in Misconceptions and Will Have Adverse Consequences

  • Feb 17, 2024

    Data Security Assessment: Complete Genomics’ US Customer Offering